Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjusted versus fixed dosage of calcium carbonate as phosphate binder in dialysis patients
TCTR20140307001Phase 4Completed
- Sponsor
- Department of Medicine, Phramongkutklao Hospital
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of calcium carbonate in end-stage kidney disease (ESKD), sponsored by Department of Medicine, Phramongkutklao Hospital. Started Feb 2013; status: completed.
02
Drugs
calcium carbonate
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20140307001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20140307001.